We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.98%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$15.8B
AUM Growth
+$2.18B
(+16%)
Cap. Flow
+$943M
Cap. Flow
% of AUM
5.96%
Top 10 Holdings %
Top 10 Hldgs %
17.79%
Holding
1,596
New
73
Increased
506
Reduced
519
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$48M |
| 2 |
Johnson Controls International
JCI
|
+$46.9M |
| 3 |
Bank of America
BAC
|
+$46.5M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$44.6M |
| 5 |
JPMorgan Chase
JPM
|
+$44.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$72.9M |
| 2 |
Pfizer
PFE
|
+$54M |
| 3 |
Essential Utilities
WTRG
|
+$35.8M |
| 4 |
Norfolk Southern
NSC
|
+$31.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Financials | 15.36% |
| 3 | Healthcare | 15.26% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Ezcorp Inc
EZPW
$1.83B
| $592K | ﹤0.01% |
86,806
| – | – |
|
|
GPOR
1052
DELISTED
Gulfport Energy Corp.
GPOR
| $592K | ﹤0.01% |
194,425
-5,031
| -3% | -$14.3K |
|
1053
Corcept Therapeutics
CORT
$12.4B
| $587K | ﹤0.01% |
48,492
| – | – |
|
|
RAVN
1054
DELISTED
Raven Industries Inc
RAVN
| $586K | ﹤0.01% |
16,994
-15,530
| -48% | -$530K |
|
1055
AdvanSix
ASIX
$541M
| $584K | ﹤0.01% |
29,236
-14,380
| -33% | -$314K |
|
1056
Bio-Rad Laboratories Class A
BIO
$8.71B
| $581K | ﹤0.01% |
+1,569
| New | +$553K |
|
1057
Agilysys
AGYS
$2.97B
| $579K | ﹤0.01% |
22,802
+8,161
| +56% | +$206K |
|
1058
Owens Corning
OC
$11.2B
| $576K | ﹤0.01% |
8,839
| – | – |
|
1059
Boise Cascade
BCC
$2.69B
| $575K | ﹤0.01% |
15,739
| – | – |
|
|
SCS
1060
DELISTED
Steelcase
SCS
| $568K | ﹤0.01% |
27,767
-24,117
| -46% | -$447K |
|
1061
Under Armour
UAA
$2.84B
| $567K | ﹤0.01% |
26,255
-840
| -3% | -$16.3K |
|
1062
Southside Bancshares
SBSI
$967M
| $566K | ﹤0.01% |
15,247
+2,689
| +21% | +$95K |
|
1063
Vistra
VST
$50B
| $559K | ﹤0.01% |
24,315
-71,740
| -75% | -$1.85M |
|
|
JBGS
1064
JBG SMITH
JBGS
$818M
| $555K | ﹤0.01% |
13,924
-1,363
| -9% | -$53.9K |
|
1065
Lantheus
LNTH
$6.49B
| $552K | ﹤0.01% |
26,909
| – | – |
|
1066
Neurocrine Biosciences
NBIX
$16.8B
| $551K | ﹤0.01% |
+5,127
| New | +$537K |
|
1067
Robert Half
RHI
$3.87B
| $551K | ﹤0.01% |
8,726
+7,650
| +711% | +$444K |
|
1068
Kforce
KFRC
$1.02B
| $543K | ﹤0.01% |
13,669
+7,485
| +121% | +$296K |
|
1069
Capri Holdings
CPRI
$1.83B
| $541K | ﹤0.01% |
14,177
-244
| -2% | -$8.42K |
|
|
JOYY
1070
JOYY Inc
JOYY
$3.71B
| $539K | ﹤0.01% |
10,212
-65
| -0.6% | -$3.83K |
|
1071
Grupo Cibest SA
CIB
$22B
| $538K | ﹤0.01% |
9,814
| – | – |
|
|
CHX
1072
DELISTED
ChampionX
CHX
| $535K | ﹤0.01% |
15,841
| – | – |
|
1073
American Superconductor
AMSC
$1.42B
| $534K | ﹤0.01% |
68,079
+16,375
| +32% | +$132K |
|
1074
CoreCivic
CXW
$2.96B
| $531K | ﹤0.01% |
30,581
| – | – |
|
1075
Ameresco
AMRC
$1.12B
| $530K | ﹤0.01% |
30,279
| – | – |
|
Similar funds
HF
KBC Group's Q4 2019 Portfolio in Review
As of Q4 2019, KBC Group held 1,596 positions worth $15.8B, up 16% from $13.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
KBC Group deployed $943M of net new capital in Q4 2019, opening 73 new positions and adding to 506 existing holdings. Its largest new stake was Toro Company: 415,537 shares worth $33.1M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $72.9M trimmed.
- KBC Group's largest Q4 2019 buy was Toro Company: 415,537 shares worth $33.1M.
- KBC Group added most to Adobe in Q4 2019, an estimated $48M increase.
- KBC Group's biggest Q4 2019 reduction was Cisco, cutting an estimated $72.9M.
- KBC Group fully exited Celgene Corp in Q4 2019, selling an estimated $28.6M.
- KBC Group's ten largest holdings make up 18% of its $15.8B portfolio in Q4 2019.
- KBC Group opened 73 new positions and closed 105 in Q4 2019.
- KBC Group's portfolio value rose 16% quarter-over-quarter to $15.8B.
Based on KBC Group's 13F filing for Q4 2019, filed 11 Feb 2020.